Clinical Trials · NCT04053270
Multicentre Phase III Erythropoietic Protoporphyria Study
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 100
- Start date
- May 2007
- Locations
- See registry
- Primary endpoint
- Cumulative Number of Days of Phototoxic Reactions (Study Efficacy Population)